Abstract
Objectives
This comparative case-matched analysis investigated feasibility and safety of direct transfemoral (TF) transcatheter aortic valve implantation (TAVI) without pre-dilatation using balloon-expandable devices.
Background
Presently, balloon aortic valvuloplasty (BAV) is considered mandatory preceding transfemoral TAVI with balloon-expandable devices. However, procedural severe adverse events may be associated with BAV.
Methods
26 consecutive patients (study group) received direct TF-TAVI using Edwards Sapien XT (n = 17) or Sapien 3 (n = 9) devices (61.5 % female, 81.3 ± 6.3 years, logEuroSCORE I 15.3 ± 13.2 %). A control group of patients after conventional TF-TAVI was retrieved from our database containing 1153 TAVI patients and matched to the study group regarding baseline and procedural data. Data reporting adheres to VARC-2 definitions.
Results
Device success was 96.2 % (25/26) and 92.3 % (24/26) in study and control groups, respectively (p = 1.00). Procedure time (60.0 ± 54.0 vs. 70.0 ± 29.1 min; p = 0.41), fluoroscopy time (13.3 ± 5.8 vs. 17.8 ± 6.9 min; p = 0.01) and amount of contrast agent (118.7 ± 47.9 vs. 153.0 ± 53.2 ml; p = 0.02) were lower in the study group. All-cause 30-day mortality was 7.7 % (2/26) in both groups, disabling stroke was observed in 3.8 % (1/26) and 7.7 % (2/26) in study and control groups, respectively. Resultant transvalvular mean gradient and effective orifice area (EOA) were 11 ± 5 vs. 11 ± 5 mmHg and 1.6 ± 0.3 vs. 1.5 ± 0.3 cm2. Paravalvular leakage ≥grade II was observed in 0 and 7.7 % (2/26; p = 0.49).
Conclusions
TF-TAVI without pre-dilatation was feasible and safe in this consecutive series of patient regardless of aortic valve morphology, for example. extent of valvular calcification or baseline EOA. This technique resulted in significantly lower fluoroscopy times and amounts of contrast agent while yielding non-inferior hemodynamic and clinical outcome.
Similar content being viewed by others
Abbreviations
- BAV:
-
Balloon-aortic valvuloplasty
- EOA:
-
Effective orifice area
- logEuroSCORE:
-
Logistic European system for cardiac operative risk evaluation I
- MSCT:
-
Multislice computed tomography
- NYHA:
-
New York Heart Association
- PM:
-
Pacemaker
- PVL:
-
Paravalvular leakage
- RVP:
-
Rapid ventricular pacing
- TA:
-
Transapical
- TAVI:
-
Transcatheter aortic valve implantation
- TEE:
-
Transesophageal echocardiography
- TF:
-
Transfemoral
- TTE:
-
Transthoracic echocardiography
- VARC:
-
Valve Academic Research Consortium
References
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 21:1597–1607
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
Walther T, Thielmann M, Kempfert J, Schroefel H, Wimmer-Greinecker G, Treede H, Wahlers T, Wendler O (2013) One-year multicentre outcomes of transapical aortic valve implantation using the SAPIEN XTTM valve: the PREVAIL transapical study. Eur J Cardiothorac Surg 43:986–992
Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62–69
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Schwedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M, ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS) (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 42:S1–S44
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajia P, Sundt TM 3rd, Thomas JD (2014) 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol [Epub ahead of print]
Vahanian A, Himbert D (2011) Transcatheter aortic valve implantation: could it be done without prior balloon valvuloplasty? JACC Cardiovasc Interv 4:758–759
Patsalis PC, Al-Rashid F, Neumann T, Plicht B, Hildebrandt HA, Wendt D, Thielmann M, Jakob HG, Heusch G, Erbel R, Kahlert P (2013) Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing. JACC Cardiovasc Interv 6:965–971
Cerillo AG, Mariani M, Berti S, Glauber M (2012) Sizing the aortic annulus. Ann Cardiothorac Surg 1:245–256
Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA (2012) SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 6:366–380
Ben-Dor I, Pichard AD, Satler LF, Goldstein SA, Syed AI, Gaglia MA Jr, Weissman G, Maluenda G, Gonzalez MA, Wakabayashi K, Collins SD, Torguson R, Okubagzi P, Xue Z, Kent M, Lindsay J, Waksman R (2010) Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv 3:1150–1156
Tissot CM, Attias D, Himbert D, Ducrocq G, Iung B, Dilly MP, Juliard JM, Lepage L, Détaint D, Messika-Zeitoun D, Nataf P, Vahanian A (2011) Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. EuroIntervention 7:49–56
Doguet F, Godin M, Lebreton G, Eltchaninoff H, Cribier A, Bessou JP, Litzler PY (2010) Aortic valve replacement after percutaneous valvuloplasty—an approach in otherwise inoperable patients. Eur J Cardiothorac Surg 38:394–399
Kahlert P, Al-Rashid F, Döttger P, Mori K, Plicht B, Wendt D, Bergmann L, Kottenberg E, Schlamann M, Mummel P, Holle D, Thielmann M, Jakob HG, Konorza T, Heusch G, Erbel R, Eggebrecht H (2011) Cerebral embolization during transcatheter aortic valve implantation: a transcranial doppler study. Circulation 126:1245–1255
Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, Kalil Filho R, Mangione J, Buellesfeld L (2011) Feasibility of transcatheter aortic valve implantation without balloon pre-dilation. JACC Cardiovasc Interv 4:751–757
Conradi L, Seiffert M, Schirmer J, Koschyk D, Blankenberg S, Reichenspurner H, Diemert P, Treede H (2014) Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe. Eur J Cardiothorac Surg 46:61–66
Wendler O, Dworakowski R, Monaghan M, MacCarthy PA (2012) Direct transapical aortic valve implantation: a modified transcatheter approach avoiding balloon predilatation. Eur J Cardiothorac Surg 42:734–736
Kempfert J, Meyer A, Kim WK, van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T (2014) First experience without pre-ballooning in transapical aortic valve implantation: a propensity score-matched analysis. Eur J Cardiothorac Surg [Epub ahead of print]
García E, Martin P, Hernandez R, Rodríguez V, Fernández A, Gama V, Almería C, Macaya C (2014) Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve. Catheter Cardiovasc Interv 83:791–795
García E, Almeria C, Unzué L, Jiménez P, Cuadrado A, Macaya C (2014) Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography. Catheter Cardiovasc Interv [Epub ahead of print]
Davies WR, Bapat VN, Hancock JE, Young CP, Redwood SR, Thomas MR (2014) Direct TAVI using a balloon-expandable system: a novel technique to eliminate pre-deployment balloon aortic valvuloplasty. EuroIntervention 10:248–252
Möllmann H, Kim WK, Kempfer J, Blumenstein J, Liebetrau C, Nef H, van Linden A, Walther T, Hamm C (2014) Transfemoral aortic valve implantation of Edwards SAPIEN XT without predilatation is feasible. Clin Cardiol [Epub ahead of print]
Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB, Valve Academic Research Consortium (VARC)-2 (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60
R Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/
Ho DE, Imai K, King G, Stuart EA (2011) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:1–28
García E, Almería C, Unzué L, Jiménez-Quevedo P, Cuadrado A, Macaya C (2014) Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography. Catheter Cardiovasc Interv 84(6):868–876
Tarantini G, Mojoli M, Purita P, Napodano M, D’Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S (2014) Unravelling the (arte)fact of increased pacemaker. EuroIntervention [Epub ahead of print]
Selle A, Figulla HR, Ferrari M, Rademacher W, Goebel B, Hamadanchi A, Franz M, Schlueter A, Lehmann T, Lauten A (2014) Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion. Clin Res Cardiol [Epub ahead of print]
Isner JM (1991) Acute catastrophic complications of balloon aortic valvuloplasty. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators. J Am Coll Cardiol 17:1436–1444
McKay RG (1991) The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 17:485–491
Serruys PW, Luijten HE, Beatt KJ, DiMario C, deFeyter PJ, Essed CE, Roelandt JR, van den Brand M (1988) Percutaneous balloon valvuloplasty for calcific aortic stenosis. A treatment ‘sine cure’. Eur Heart J 9:782–794
Konigstein M, Ben-Assa E, Abramowitz Y, Steinvil A, Leshem Rubinow E, Havakuk O, Arbel Y, Halkin A, Keren G, Banai S, Finkelstein A (2013) Usefulness of updated valve academic research consortium-2 criteria for acute kidney injury following transcatheter aortic valve implantation. Am J Cardiol 112(11):1807–1811
Khawaja MZ, Thomas M, Joshi A, Asrress KN, Wilson K, Bolter K, Young CP, Hancock J, Bapat V, Redwood S (2012) The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 8(5):563–570
Conflict of interest
Lenard Conradi, Hendrik Treede, Ulrich Schäfer and Patrick Diemert are consultants to Edwards Lifesciences.
Author information
Authors and Affiliations
Corresponding author
Additional information
L. Conradi and A. Schaefer contributed equally to this work.
Rights and permissions
About this article
Cite this article
Conradi, L., Schaefer, A., Seiffert, M. et al. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis. Clin Res Cardiol 104, 735–742 (2015). https://doi.org/10.1007/s00392-015-0836-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0836-1